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Editorial
Models of healthcare in 
respiratory diseases
Increasing healthcare cost and utilisation of health 
services have sparked an interest in new models 
of care, especially those that allow provision of 
traditional inpatient care in a community setting. 
COVID-19 has accelerated the implementation of 
telehealth, the delivery of medical care via phone 
or digital communication.
Remote monitoring of patients with COVID-19 
who are well enough to stay at home but are at 
risk of clinical deterioration allows us to monitor 
changes in symptoms and vital signs such as oxygen 
saturation (SpO2), heart rate, blood pressure and 
temperature. Monitoring is enabled by surveys/
diaries [1] and connected devices [2]. This facilitates 
timely intervention by the care team if the patient’s 
condition worsens. Remote monitoring of SpO2 
has also been used in patients with COVID-19 
pneumonia discharged from hospital to detect 
those who acutely deteriorate and require urgent 
assessment and potential hospital readmission [2]. 
Monitoring at home has the potential to reduce 
the need for hospital admissions and the length 
of hospital stays, therefore allowing focusing of 
resources on those most in need of hospital care.
Chronic respiratory diseases may lend 
themselves to remote monitoring. With the current 
push to digital health, we will probably see an 
explosion in home monitoring health services. The 
evidence for the effectiveness of such interventions 
in chronic respiratory diseases is currently, however, 
insufficient. Large high-quality randomised trials 
are required to establish the effectiveness of home 
monitoring programmes in chronic respiratory 
diseases before they are rolled out as part of routine 
healthcare.
In asthma, remote monitoring has been shown 
to be an effective tool to identify nonadherence in 
individuals with difficult-to-control asthma using 
suppression of fractional exhaled nitric oxide with 
directly observed therapy of inhaled corticosteroids 
over 7 days [3]. This approach has the potential to 
identify patients who are likely to respond to high-
dose inhaled corticosteroids and those who, despite 
good adherence to inhaled corticosteroids, are likely 
to require additional treatment [3]. A randomised 
trial of a home monitoring programme on top 
of standard care for 24 weeks in patients with 
idiopathic pulmonary fibrosis did not show any 
significant difference in the primary outcome 
of health-related quality of life compared with 
standard care only [4]. The intervention included 
home spirometry, reporting of symptoms and side-
effects, patient-reported outcomes, information, a 
medication coach, and online consultations [4]. In 
COPD, a three-arm randomised trial evaluating the 
effectiveness of a remote monitoring and a self-
monitoring programme did not show any significant 
differences in self-management skills, knowledge, 
symptoms, or healthcare use compared with each 
other or with a standard care group [5].
COVID-19 has highlighted a lack of care 
coordination between hospitals and aged care 
homes, a problem that is often encountered in 
patients with chronic conditions as well.
In this issue of Breathe, different aspects 
of health service provision to patients with 
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respiratory diseases will be highlighted, including 
improving continuity of care of respiratory 
patients at time of hospital admission and 
discharge [6], multidisciplinary care for patients 
with neuromuscular disease [7], outpatient 
treatment for pulmonary embolism, and the timing 




1Institute for Evidence-Based Healthcare, Bond University, Robina, Australia. 2Dept of Respiratory Medicine, Liverpool 




 1. Annis T, Pleasants S, Hultman G, et al. Rapid implementation 
of a COVID-19 remote patient monitoring program. J Am Med 
Inform Assoc 2020; 27: 1326–1330. 
 2. O’Carroll O, MacCann R, O’Reilly A, et al. Remote monitoring of 
oxygen saturation in individuals with COVID-19 pneumonia. 
Eur Respir J 2020; 56: 2001492. 
 3. Heaney LG, Busby J, Bradding P, et al. Remotely monitored 
therapy and nitric oxide suppression identifies nonadherence in 
severe asthma. Am J Respir Crit Care Med 2019; 199: 454–464. 
 4. Moor CC, Mostard RLM, Grutters JC, et al. Home monitoring 
in patients with idiopathic pulmonary fibrosis. a randomized 
controlled trial. Am J Respir Crit Care Med 2020; 202: 393–401. 
 5. Stamenova V, Liang K, Yang R, et al. Technology-enabled self-
management of chronic obstructive pulmonary disease with 
or without asynchronous remote monitoring: randomized 
controlled trial. J Med Internet Res 2020; 22: e18598. 
 6. Dummer J, Stokes T. Improving continuity of care of patients 
with respiratory disease at hospital discharge. Breathe 2020; 
16: 200161. 
 7. Shah NM, Murphy PB, Kaltsakas G. The adult multidisciplinary 
respiratory neuromuscular clinic. Breathe 2020; 16: 
200121. 
 8. Strutt R. When to refer patients with advanced COPD to 
palliative care services. Breathe 2020; 16: 200061. 
